[Initial experience in the treatment of bronchiolitis using heparin]

Area of Science:

• Pediatrics
• Pulmonology
• Pharmacology

Context:

• Bronchiolitis is a common respiratory infection in infants.
• Current treatment primarily involves supportive care.
• The efficacy of adjunctive heparin therapy requires further investigation.

Purpose:

• To evaluate the efficacy of sodium heparin as an adjunct to supportive therapy in pediatric patients diagnosed with bronchiolitis.
• To compare the duration of illness and symptom persistence between infants treated with heparin and those receiving only supportive care.

Summary:

• A study involving 30 infants with bronchiolitis compared supportive care alone versus supportive care plus intravenous sodium heparin (50 U/Kg/24 h for 24-36 hours).
• The heparin-treated group demonstrated a significantly shorter mean duration of illness (3.06 days) compared to the control group (5.53 days, p < 0.001).
• Symptom persistence was also considered, with preliminary positive outcomes in the heparin group.

Impact:

• Findings suggest that heparin may be a beneficial addition to standard supportive care for bronchiolitis in children.
• The study highlights a potential new therapeutic avenue for managing pediatric bronchiolitis.
• Further extensive research is warranted to confirm these promising results and establish definitive clinical guidelines.